Emil von Behrings was called to Marburg as Director of the Hygiene Institute and an academic teacher.
The world's first Nobel prize for Medicine went to Emil von Behring for his pioneering work in serum therapy against diphtheria.
Foundation of the "Behringwerk" in Marburg by Emil von Behring. He used the prize money that he had received for the Nobel Prize as start-up capital. The entrepreneur and physician thus created the basis for a global pharmaceutical organisation.
The site has continuously developed and evolved since the beginning.
It remains true to its roots and quality standards to this day.
In addition to the three global companies CSL Behring, Novartis Vaccines and Siemens Research, a total of 16 companies research, produce and sell their products from Marburg all over the world.
In contrast to the chemical parks found throughout Germany, this industrial park has developed into a modern biotechnology centre. As operator of the industrial park, Pharmaserv cooperates closely with the companies on site to continue to optimise the infrastructure. The industrial park is specifically geared to pharmaceutical, biotechnology and nanotechnology companies.